Publication: Patent foramen ovale closure vs. medical therapy for recurrent stroke prevention: Evolution of treatment effect during follow-up.
cris.virtual.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtual.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtualsource.author-orcid | b83848b4-8f34-4f09-bf3b-e39d366ea8e8 | |
cris.virtualsource.author-orcid | 31134751-5aa4-429b-82a9-a4f94bac9190 | |
cris.virtualsource.author-orcid | 987e86fe-121f-4490-8444-9a22622c19f7 | |
cris.virtualsource.author-orcid | 5c8247bd-3b6a-428b-a426-5f9725e9e9a4 | |
cris.virtualsource.author-orcid | b7cda86d-8924-42a5-973a-d73fee5c630b | |
cris.virtualsource.author-orcid | b620722a-f94f-4ba9-b338-16a38af6d7d0 | |
cris.virtualsource.author-orcid | 101f1394-72d5-4dda-b28f-666a3dee6c70 | |
dc.contributor.author | Piccolo, Raffaele | |
dc.contributor.author | Stortecky, Stefan | |
dc.contributor.author | Franzone, Anna | |
dc.contributor.author | Siontis, Georgios | |
dc.contributor.author | Pilgrim, Thomas | |
dc.contributor.author | Meier, Bernhard | |
dc.contributor.author | Windecker, Stephan | |
dc.date.accessioned | 2024-10-08T15:10:50Z | |
dc.date.available | 2024-10-08T15:10:50Z | |
dc.date.issued | 2018-03-15 | |
dc.description.abstract | BACKGROUND Little is known regarding changes in treatment effect over time associated with patent foramen ovale (PFO) closure among patients with embolic stroke of unknown origin. METHODS We reconstructed Kaplan-Meier curves for stroke from individual randomized trials comparing PFO closure vs. medical therapy among patients with embolic stroke. Random effects Cox-regression analyses were performed in order to estimate hazard ratios (HRs) with 95% confidence intervals (95%CIs). RESULTS A total of 2531 patients enrolled across 4 randomized trials were included. PFO closure was associated with a significant reduction in the risk of stroke at longest available follow-up (HR 0.18, 95%CI 0.06 to 0.59, P=0.005). However, recurrent stroke was already significantly reduced among patients randomized to PFO closure at 1-year (HR 0.40, 95%CI 0.20 to 0.80, P=0.010), with the treatment effect remaining consistent (P-for-interaction=0.356) between 1- and 5-year (HR 0.14, 95%CI 0.05 to 0.55, P=0.005) and beyond 5-year (HR 0.20, 95%CI 0.03 to 1.19, P=0.077). CONCLUSIONS Among patients with embolic stroke of unknown origin, PFO closure reduces the risk of stroke compared with medical therapy, with a significant reduction in recurrences starting already within 1-year after percutaneous PFO closure. | |
dc.description.numberOfPages | 3 | |
dc.description.sponsorship | Universitätsklinik für Kardiologie | |
dc.description.sponsorship | Emeriti, Medizinische Fakultät | |
dc.identifier.doi | 10.7892/boris.125247 | |
dc.identifier.pmid | 29338916 | |
dc.identifier.publisherDOI | 10.1016/j.ijcard.2018.01.001 | |
dc.identifier.uri | https://boris-portal.unibe.ch/handle/20.500.12422/63307 | |
dc.language.iso | en | |
dc.publisher | Elsevier | |
dc.relation.ispartof | International journal of cardiology | |
dc.relation.issn | 0167-5273 | |
dc.relation.organization | DCD5A442BB15E17DE0405C82790C4DE2 | |
dc.subject | Embolic stroke Meta-analysis Patent foramen ovale | |
dc.subject.ddc | 600 - Technology::610 - Medicine & health | |
dc.title | Patent foramen ovale closure vs. medical therapy for recurrent stroke prevention: Evolution of treatment effect during follow-up. | |
dc.type | article | |
dspace.entity.type | Publication | |
dspace.file.type | text | |
oaire.citation.endPage | 31 | |
oaire.citation.startPage | 29 | |
oaire.citation.volume | 255 | |
oairecerif.author.affiliation | Universitätsklinik für Kardiologie | |
oairecerif.author.affiliation | Universitätsklinik für Kardiologie | |
oairecerif.author.affiliation | Universitätsklinik für Kardiologie | |
oairecerif.author.affiliation | Universitätsklinik für Kardiologie | |
oairecerif.author.affiliation | Universitätsklinik für Kardiologie | |
oairecerif.author.affiliation | Emeriti, Medizinische Fakultät | |
oairecerif.author.affiliation | Universitätsklinik für Kardiologie | |
oairecerif.author.affiliation2 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation2 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation2 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation2 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation2 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation2 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation2 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation3 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation3 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation3 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation3 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation3 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation3 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation3 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation4 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation4 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation4 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation4 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation4 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation4 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
oairecerif.author.affiliation4 | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.date.licenseChanged | 2019-10-23 06:08:48 | |
unibe.description.ispublished | pub | |
unibe.eprints.legacyId | 125247 | |
unibe.journal.abbrevTitle | INT J CARDIOL | |
unibe.refereed | TRUE | |
unibe.subtype.article | journal |
Files
Original bundle
1 - 1 of 1
- Name:
- Patent foramen ovale closure vs. medical therapy for recurrent stroke prevention.pdf
- Size:
- 276.74 KB
- Format:
- Adobe Portable Document Format
- File Type:
- text
- License:
- publisher
- Content:
- published